Related Experiment Video
Updated: Jul 3, 2025
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics
Shi-Ming Tu1, Jim Z Chen1, Sunny R Singh1
1Division of Hematology and Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Abstract:
Although Otto Warburg may be right about the role of glycolysis versus OXPHOS in cancer metabolism, it remains unclear whether an altered metabolism is causative or correlative and is the main driver or a mere passenger in the pathogenesis of cancer. Currently, most of our successful treatments are designed to eliminate non-cancer stem cells (non-CSCs) such as differentiated cancer cells. When the treatments also happen to control CSCs or the stem-ness niche, it is often unintended, unexpected, or undetected for lack of a pertinent theory about the origin of cancer that clarifies whether cancer is a metabolic, genetic, or stem cell disease. Perhaps cellular context matters. After all, metabolic activity may be different in different cell types and their respective microenvironments-whether it is in a normal progenitor stem cell vs. progeny differentiated cell and whether it is in a malignant CSC vs. non-CSC. In this perspective, we re-examine different types of cellular metabolism, e.g., glycolytic vs. mitochondrial, of glucose, glutamine, arginine, and fatty acids in CSCs and non-CSCs. We revisit the Warburg effect, an obesity epidemic, the aspartame story, and a ketogenic diet. We propose that a pertinent scientific theory about the origin of cancer and of cancer metabolism influences the direction of cancer research as well as the design of drug versus therapy development in cancer care.
Insights
Cancer metabolism, particularly the Warburg effect, is re-examined in cancer stem cells (CSCs) versus non-CSCs. Understanding cancer
Area of Science:
- Oncology
- Cancer Metabolism
- Cellular Biology
Background:
- The role of cellular metabolism, specifically the Warburg effect (glycolysis vs. oxidative phosphorylation), in cancer pathogenesis remains debated.
- Current cancer treatments primarily target non-cancer stem cells (non-CSCs), often with unintended effects on cancer stem cells (CSCs).
- A clear understanding of cancer's origin—whether metabolic, genetic, or stem cell-driven—is lacking, impacting research and therapeutic development.
Purpose of the Study:
- To re-examine cellular metabolism in cancer stem cells (CSCs) versus non-CSCs.
- To explore the influence of cellular context and microenvironment on metabolic differences.
- To propose how a unified theory of cancer origin and metabolism can guide future research and drug development.
Main Methods:
- Review and re-examination of existing literature on cancer metabolism.
- Comparative analysis of metabolic pathways (glycolysis, oxidative phosphorylation) in CSCs and non-CSCs.
- Discussion of factors including the Warburg effect, obesity, aspartame, and ketogenic diets in relation to cancer metabolism.
Main Results:
- Metabolic activity, including glucose, glutamine, arginine, and fatty acid utilization, likely differs significantly between CSCs and non-CSCs.
- Cellular context and microenvironment play a crucial role in shaping cancer metabolism.
- Current therapeutic strategies may be suboptimal due to an incomplete understanding of cancer's metabolic drivers.
Conclusions:
- A comprehensive theory integrating cancer origin and metabolism is essential for advancing cancer research.
- Understanding metabolic heterogeneity is critical for developing effective cancer therapies targeting CSCs.
- Future research should focus on elucidating the causative role of metabolic alterations in cancer and developing targeted metabolic therapies.
More Related Videos
Related Concept Videos
02:40Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:12What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
02:21Cancers Originate from Somatic Mutations in a Single Cell